COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration
Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.
The emergence of multiple SARS-CoV-2 variants brings fast-moving questions for clinical laboratory administrators about the ability to identify these new variants. A new mutation panel may offer an alternative to viral genome sequencing for indicating the possible presence of these variants.
The new research indicating a time-dependent result for COVID-19 testing may have significant implications for the clinical laboratories.
Use of this technology could be preventive, administered to people before they have an infection, says Rensselaer professor.
A sustained drop in COVID-19 diagnostic testing could present the clinical laboratory industry with opportunities, but it could also lead to potential damages if not handled proactively and correctly.
How the state plans to address potential waste of COVID-19 tests.
This new SARS-CoV-2 study carries risks and controversy.
The emergence of multiple SARS-CoV-2 variants brings fast-moving questions for clinical laboratory administrators about the ability to identify these new variants. A new mutation panel may offer an alternative to viral genome sequencing for indicating the possible presence of these variants.
The new research indicating a time-dependent result for COVID-19 testing may have significant implications for the clinical laboratories.
Use of this technology could be preventive, administered to people before they have an infection, says Rensselaer professor.
A sustained drop in COVID-19 diagnostic testing could present the clinical laboratory industry with opportunities, but it could also lead to potential damages if not handled proactively and correctly.
How the state plans to address potential waste of COVID-19 tests.
This new SARS-CoV-2 study carries risks and controversy.
